🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study adopted a single-center, randomized, double-blind, placebo-contr...
Status
Completed
Location
Beijing Anzhen Hospital, Capital Medical University
Start Date
2025-08-06
Trial ID
NCT07083362
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of autolog...
Status
Unknown
Location
Yaguo Li
Start Date
2012-01
Trial ID
NCT01518231
Edaravone has demonstrated a beneficial effect in promoting remyelination a...
Status
Recruiting
Location
Yi Du
Start Date
2022-01-15
Trial ID
NCT05540262
Treatments Being Tested
This is a Phase 1, Randomized, Open-Label, Three-Treatment, Three-Period Cr...
Status
Completed
Location
ICON Early Phase Services
Start Date
2023-11-07
Trial ID
NCT06107205
Treatments Being Tested
Edaravone, a free radical scavenger, is a novel neuroprotective agent, and ...
Status
Completed
Location
EAST Study Office c/o National Cardiovascular Center
Start Date
2004-08
Trial ID
NCT00153946
Treatments Being Tested
EXCELLENT was a prospective, multicenter, randomized, double-blind, placebo...
Status
Recruiting
Location
Beijing Tiantan Hospital of Capital Medical University
Start Date
2024-08-01
Trial ID
NCT07119021
Treatments Being Tested
The primary objective is to evaluate the safety and tolerability of single ...
Status
Unknown
Location
OSF Healthcare System d/b/a Saint Francis Medical
Start Date
2018-10-25
Trial ID
NCT03495206
Treatments Being Tested
Study on the Safety, Tolerance and Pharmacokinetics of Single-dose, Increas...
Status
Completed
Location
Beijing Tiantan Hospital, Capital Medical University
Start Date
2019-06-05
Trial ID
NCT04219865
pending...
Status
Unknown
Location
Multiple Locations
Start Date
2021-03-01
Trial ID
NCT04714177
Treatments Being Tested
To evaluate the pharmacokinetics safety, and tolerability of single and mul...
Status
Completed
Location
Investigational Site
Start Date
2018-03-20
Trial ID
NCT04481750
Treatments Being Tested